Close Menu

NEW YORK  — Chronic disease laboratory company Salveo Diagnostics this week announced its acquisition of autoimmune-focused diagnostics firm ImmunArray and health engagement platform Nudge.

Financial and other terms of the deal were not released.

The firms said the merger will expand Salveo's testing abilities and improve communication between providers and patients while also allowing patients to access lab results on their smartphones.

All three companies are based in Richmond, Virginia. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.